Keyphrases
Patients with Advanced Cancer
100%
Maximum Tolerated Dose
100%
Pharmacokinetic Study
100%
Phase I Study
100%
Phenoxodiol
100%
Nausea
50%
Intravenous Administration
50%
Pharmacokinetics
50%
Plasma Samples
50%
Alkaline Phosphatase
50%
Intravenous Infusion
50%
Genistein
50%
Progressive Disease
50%
Dose Level
50%
Volume of Distribution
50%
Best Response
50%
Stable Disease
50%
Transaminases
50%
Pharmacokinetic Profile
50%
Lymphocytopenia
50%
Flavopiridol
50%
Plasma Half-life
50%
Escalating Dose
50%
Pharmacology, Toxicology and Pharmaceutical Science
Advanced Cancer
100%
Pharmacokinetic
100%
Idronoxil
100%
Diseases
28%
Maximum Tolerated Dose
28%
Nausea
14%
Allergic Reaction
14%
Alkaline Phosphatase
14%
Genistein
14%
Aminotransferase
14%
Volume of Distribution
14%
Dose Toxicity
14%
Flavopiridol
14%
Lymphocytopenia
14%